Kathleen Cunningham

Kathleen Cunningham has a diverse work experience in the field of biotherapeutics and research. Kathleen is currently working as a Scientist 1 at A2 Biotherapeutics, Inc. since July 2022. Prior to this, Kathleen worked as a Postdoctoral Scholar at the University of California, Los Angeles from August 2019 to July 2022. Kathleen also gained valuable experience as a PhD Candidate at Johns Hopkins University from August 2013 to July 2019. Kathleen started their career as an Intern at Biogen Idec in June 2012 and later worked as a Research Student at Beth Israel Deaconess Medical Center from January 2012 to March 2012.

Kathleen Cunningham has a strong educational background with a specialization in cellular and molecular medicine. Kathleen pursued a Bachelor of Arts (A.B.) degree from Dartmouth College, majoring in Biology/Biological Sciences from 2009 to 2013. Following their undergraduate studies, Kathleen enrolled at The Johns Hopkins University School of Medicine from 2013 to 2019, where they completed their Doctor of Philosophy (Ph.D.) in Cellular and Molecular Medicine.